Pfizer has appointed the executive leadership team for the combined Pfizer and Allergan business following the close of the transaction. Brent Saunders will become president and chief operating officer of the combined company with responsibility for the oversight of Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy functions. Effective immediately, Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines, Oncology and Consumer (VOC) business will opera...